FDA calendar and trial changes: week to 12 November 2026
Week to 12 Nov 2026: 5 FDA calendar events in the next 60 days, 6 clinical trial record changes on ClinicalTrials.gov. Every item links to its source.
On the FDA calendar, next 60 days
| Date as reported | Drug / company | Event | Evidence |
|---|---|---|---|
| 30 Nov 2026 | bezuclastinibCogent Biosciences, Inc. (COGT) | PDUFA dateGIST | Open original source |
| 22 Dec 2026 | LorundrostatMineralys Therapeutics Inc. (MLYS) | PDUFA datehypertension in combination with other antihypertensive drugs | Open original source |
| 22 Dec 2026 | LorundrostatMineralys Therapeutics Inc. (MLYS) | PDUFA datetreatment of hypertension in combination with other antihypertensive drugs | Open original source |
| 30 Dec 2026 | bezuclastinibCogent Biosciences, Inc. (COGT) | PDUFA dateNonAdvSM | Open original source |
| 30 Dec 2026 | bezuclastinibCogent Biosciences, Inc. (COGT) | PDUFA dateNonAdvSM | Open original source |
Trial record changes this week
NCT06292923 · Tiziana Life Sciences LTD (TLSA)
Primary completion date changed
Before: Sep 2026. After: 17 Sep 2026.
Recruitment status changed
Before: Active not recruiting. After: Completed.
Participant count type changed
Before: Estimated. After: Actual.
Completion date type changed
Before: Estimated. After: Actual.
NCT05093634 · Rhythm Pharmaceuticals, Inc. (RYTM)
Primary completion date changed
Before: 22 Dec 2025. After: 19 Dec 2025.
Main study measure wording changed
Compare the two versions on the trial page.
NCT07290569 · Oruka Therapeutics, Inc. (ORKA)
Primary completion date changed
Before: Jun 2027. After: 21 Oct 2026.
Completion date type changed
Before: Estimated. After: Actual.
NCT07157007 · Traws Pharma, Inc. (TRAW)
Primary completion date changed
Before: Feb 2026. After: 16 Feb 2026.
Participant count changed
Before: 90 participants (planned). After: 93 participants (actual).
Recruitment status changed
Before: Recruiting. After: Completed.
Participant count type changed
Before: Estimated. After: Actual.
Completion date type changed
Before: Estimated. After: Actual.
NCT07916480 · Arcutis Biotherapeutics, Inc. (ARQT)
Recruitment status changed
Before: Not yet recruiting. After: Recruiting.
NCT05717920 · Aldeyra Therapeutics, Inc. (ALDX)
Main study measure wording changed
Compare the two versions on the trial page.